GlassScriptPhysician profile
Todd A Spencer
NPI 1952343857
$5,791.24
in general payments reported to CMS, 2019-2025
38 companies · $557 in 2025
The $557 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,129 · 2020: $646 · 2021: $874 · 2022: $648 · 2023: $797 · 2024: $1,141 · 2025: $557.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,494.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,494.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $1,337.99 | 2019-2025 | Gore Tag Conformable Thoracic Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Tag Thoracic Branch Endoprosthesis |
| Silk Road Medical, INC. | $783.18 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Cardiovascular Systems INC. | $734.47 | 2019-2023 | Diamondback Peripheral |
| Boston Scientific Corporation | $699.68 | 2019-2025 | Eluvia, Ranger, Enroute Transcarotid Stent |
| Endologix LLC | $306.45 | 2024-2025 | Torus Stent Graft System, Endocross Device, Alto Abdominal Stent Graft System |
| Cvrx, INC. | $175.40 | 2022-2024 | Barostim Neo System |
| Cook Medical LLC | $168.59 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $139.25 | 2019-2021 | |
| Ossur Americas, INC. | $125.80 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $107.53 | 2023-2024 | Andexxa |
| Bard Peripheral Vascular, INC. | $106.09 | 2019-2023 | Venovo |
| Baxter Healthcare | $102.82 | 2019-2025 | Perclot, Floseal |
| Smith+Nephew, INC. | $95.66 | 2019-2021 | |
| Imperative Care, INC | $72.30 | 2025 | Prodigy Catheter, Symphony Catheter |
| Shockwave Medical, INC | $63.45 | 2020-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $63.23 | 2021-2022 | |
| Elutia, INC. | $61.16 | 2019-2020 | |
| Tactile Systems Technology INC | $56.27 | 2019-2020 | |
| Becton, Dickinson and Company | $48.33 | 2019-2025 | Lifestream |
| Angiodynamics, INC. | $44.38 | 2020-2021 | |
| Terumo Medical Corporation | $44.21 | 2019-2025 | Navicross |
| Philips North America LLC | $41.95 | 2019 | |
| Cardinal Health 200 LLC | $35.58 | 2019-2020 | |
| Reflow Medical INC | $33.39 | 2024 | |
| Biocompatibles, INC. | $31.35 | 2019 | |
| Bolton Medical INC | $31.10 | 2023 | Treo Abdominal Stent-Graft System |
| Acacia Pharma INC | $31.05 | 2021 | |
| Contego Medical, INC | $30.79 | 2023-2024 | Paladin |
| Acell, INC. | $30.01 | 2020 | |
| Ethicon US, LLC | $29.82 | 2021 | |
| Abbott Laboratories | $28.41 | 2023 | Diamondback Peripheral |
| Getinge USA Sales, LLC | $23.61 | 2019-2020 | |
| Musculoskeletal Transplant Foundation INC. | $21.63 | 2022 | |
| Mindray Ds USA, INC. | $19.89 | 2023 | Te X, Te7 Max |
| Integra Lifesciences Corporation | $19.11 | 2021 | |
| Inari Medical, INC. | $16.57 | 2019 | |
| Medtronic Vascular, INC. | $16.53 | 2020 | |
| Kci USA, INC. | $14.21 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Spencer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.